Shannon John Patrick Jr (CIK 1553595) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-21). Recent activity: Sell XERS (36,645 shares), Buy XERS (478,436 shares), Sell XERS (118,134 shares), Sell XERS (111,621 shares), Sell XERS (110,750 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-21 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer and Chairman of the Board | Sell | 36,645 | $296,092 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer and Director | Buy | 478,436 | $0 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer and Director | Sell | 118,134 | $869,466 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer and Director | Sell | 111,621 | $821,531 |
| 2026-02-02 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer and Director | Sell | 110,750 | $815,120 |
| 2026-01-06 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer and Director | Sell | 24,907 | $176,342 |
| 2026-01-06 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer and Director | Buy | 64,265 | $99,611 |
| 2026-01-06 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer and Director | Buy | 25,136 | $38,961 |
| 2026-01-06 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer and Director | Buy | 2,900 | $11,426 |
| 2025-11-17 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer and Director | Buy | 8,970 | $13,904 |
| 2025-11-17 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer and Director | Sell | 23,242 | $173,385 |
| 2025-11-17 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer and Director | Buy | 87,100 | $135,005 |
| 2025-08-04 | Xeris Biopharma Holdings, Inc. (XERS) | Chief Executive Officer and Director | Sell | 36,918 | $198,619 |
来源：SEC Form 4 申报文件 · 截至 2026-08-21